prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumB, page 1 / 2. Examination: Histopathological examination (cito). Cost of diagnostic procedure. Gender: F. Material: Multiple organ resection - right breas with axillary tissues. Unit in charge: : Expected time of examination: 5 working days. Clinical diagnosis: Macroscopic description: Right breast, sized 24.8 x 19.3 x 5.2 cm, removed with axillary tissues sized 8.0 x 7.5 x 3.0 cm and a skin flap of 28.6 x 14.6 cm. Tumour sized 2.2 x 1.7 x 2.4 found in the lower outer quadrant, located 5.2 cm from the lower boundary, 1.7 cm from the base. and 0 cm from the skin. Microscopic description: Carcinoma ductale invasivum NHG3 (3+3+2: 10 mitoses/10 HPF - visual area 0.55 mm). Mamillae sine laesionibus. Glandular tissue showing parenchymal atrophy. Axillary lymph nodes: Lymphonodulitis chronica (No VII). Histopathological diagnosis: Carcinoma ductale invasivum mammae dextrae. Invasive ductal carcinoma of the right breast. (NHG3, pT2, pNO). Results of immunohistochemical examination: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in less than 10% of neoplastic cell. nuclei. HER2 protein stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody. Score=2+, FISH verification. recommended. Examination: Histopathological examination (cito). page 2 / 2. Gender: F. Result of immunohistochemical examination: RESULT OF HER2/neu GENE AMPLIFICATION with the FISH method by Path Vysion HER2 DNA Probe Kit. HER-2 GENE AMPLIFICATION NOT FOUND.

expanded version (tokens=848) : 
 Here is the breakdown of the information extracted from the breast pathology report:

1. Histological classification: The patient has invasive ductal carcinoma of the right breast which is also known as luminal B subtype.

2. Subtype: The cancer subtype is LumB.

3. Necrosis: There is no mention of necrosis in the report.

4. Tumor infiltrating lymphocytes: There is no mention of tumor infiltrating lymphocytes in the report.

5. Histological grade: The histological grade of the cancer is 3 (NHG3).

6. Nuclear grade: The nuclear grade is not specifically mentioned in the report but NHG3 refers to a moderately differentiated cancer (Grade 2-3).

7. Lymphovascular invasion: There is no mention of lymphovascular invasion in the report.

8. Calcification: There is no mention of calcification in the report.

9. Receptor status: Estrogen receptors found in over 75% of neoplastic cell nuclei. Progesterone receptors found in less than 10% of neoplastic cell nuclei.

10. IHC and ancillary testing results: HER2 protein was stained with Ventana's Pathway HER-2/neu (4B5) rabbit antibody which yielded a score of 2+. FISH verification was recommended to confirm the HER2 status. The FISH method by Path Vysion HER2 DNA Probe Kit revealed that HER-2 gene amplification was not

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=988) : 
 The report indicates the patient has LumB subtype invasive ductal carcinoma. Histological grade is 3. No necrosis or lymphovascular invasion present. Receptor status shows the presence of estrogen receptors in over 75% of neoplastic cell nuclei; however, progesterone receptors were found in less than 10%. HER2 score was 2+ and FISH verification was recommended for confirmation which later revealed no HER-2 gene amplification.

